90
- Liang X, Potter J, Kumar S, Zou Y, Quintanilla R, Sridharan M, et al. Rapid and highly efficient
mammalian cell engineering via Cas9 protein transfection. J Biotechnol. 2015;208:44–53. - Sung YH, Kim JM, Kim HT, Lee J, Jeon J, Jin Y, et al. Highly efficient gene knockout in mice
and zebrafish with RNA-guided endonucleases. Genome Res. 2014;24(1):125–31. - Horii T, Arai Y, Yamazaki M, Morita S, Kimura M, Itoh M, et al. Validation of microinjection
methods for generating knockout mice by CRISPR/Cas-mediated genome engineering. Sci
Rep. 2014;4:4513. - Singh P, Schimenti JC, Bolcun-Filas E. A mouse geneticist’s practical guide to CRISPR appli-
cations. Genetics. 2015;199(1):1–15. - Hashimoto M, Takemoto T. Electroporation enables the efficient mRNA delivery into the
mouse zygotes and facilitates CRISPR/Cas9-based genome editing. Sci Rep. 2015;5:11315. - Qin W, Dion SL, Kutny PM, Zhang Y, Cheng AW, Jillette NL, et al. Efficient CRISPR/
Cas9-mediated genome editing in mice by zygote electroporation of nuclease. Genetics.
2015;200(2):423–30. - Wang W, Kutny PM, Byers SL, Longstaff CJ, DaCosta MJ, Pang C, et al. Delivery of Cas9
protein into mouse zygotes through a series of electroporation dramatically increases the effi-
ciency of model creation. J Genet Genomics. 2016;43(5):319–27. - Chen S, Lee B, Lee AY, Modzelewski AJ, He L. Highly efficient mouse genome editing by
CRISPR ribonucleoprotein electroporation of zygotes. J Biol Chem. 2016;291(28):14457–67. - Boroviak K, Doe B, Banerjee R, Yang F, Bradley A. Chromosome engineering in zygotes with
CRISPR/Cas9. Genesis. 2016;54(2):78–85. - Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, et al. Repurposing
CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell.
2013;152(5):1173–83. - Kim K, Ryu SM, Kim ST, Baek G, Kim D, Lim K, et al. Highly efficient RNA-guided base
editing in mouse embryos. Nat Biotechnol. 2017. - Liu XS, Wu H, Ji X, Stelzer Y, Wu X, Czauderna S, et al. Editing DNA methylation in the
mammalian genome. Cell. 2016;167(1):233–47.E17. - Iyer V, Shen B, Zhang W, Hodgkins A, Keane T, Huang X, et al. Off-target mutations are rare
in Cas9-modified mice. Nat Methods. 2015;12(6):479. - Seruggia D, Fernandez A, Cantero M, Pelczar P, Montoliu L. Functional validation of mouse
tyrosinase non-coding regulatory DNA elements by CRISPR-Cas9-mediated mutagenesis.
Nucleic Acids Res. 2015;43(10):4855–67. - Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, et al. High-fidelity
CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature.
2016;529(7587):490–5. - Slaymaker IM, Gao L, Zetsche B, Scott DA, Yan WX, Zhang F. Rationally engineered Cas9
nucleases with improved specificity. Science (New York, NY). 2016;351(6268):84–8.
C.L. Yuan and Y.-C. Hu